PHK
DNLI icon

Point72 Hong Kong’s Denali Therapeutics DNLI Stock Holding History

Point72 Hong Kong’s Portfolio DNLI Stock Details DNLI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-3,175
Closed -$64.7K – 525
2024
Q4 		$64.7K Buy
+3,175
New +$81.3K ﹤0.01% 323
2022
Q4 		– Sell
-4,753
Closed -$146K – 531
2022
Q3 		$146K Buy
+4,753
New +$155K 0.01% 1130
2022
Q2 		– Sell
-1,194
Closed -$38K – 2028
2022
Q1 		$38K Sell
1,194
-125
-9% -$4.3K ﹤0.01% 1407
2021
Q4 		$59K Buy
1,319
+420
+47% +$19.9K 0.01% 1301
2021
Q3 		$45K Buy
+899
New +$50.7K ﹤0.01% 1546
2020
Q2 		– Sell
-120
Closed -$2K – 1197
2020
Q1 		$2K Buy
+120
New +$2.5K ﹤0.01% 843
2018
Q1 		– Sell
-13,043
Closed -$204K – 956
2017
Q4 		$204K Buy
+13,043
New +$234K 0.16% 55

Other funds holding DNLI

BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $29.7B AUM 13.98% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return